» Articles » PMID: 29854278

Identification and Functional Characterization of CircRNA-0008717 As an Oncogene in Osteosarcoma Through Sponging MiR-203

Overview
Journal Oncotarget
Specialty Oncology
Date 2018 Jun 2
PMID 29854278
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Circular RNA (circRNA) is a key regulator in the development and progression of human cancers, however its role in osteosarcoma tumorigenesis is not well understood. The present study aims to investigate the expression profiles and potential modulation of circRNA on osteosarcoma carcinogenesis. Human circRNA microarray was performed to screen for abnormally expressed circRNA in osteosarcoma tissue and circRNA-0008717 was identified as one circRNA significantly upregulated in osteosarcoma tissue. Osteosarcoma patients with high circRNA-0008717 expression had shortened survival. Gain and loss functional assays suggested that knockdown of circRNA-0008717 suppressed cell proliferation, migration and invasion, but promoted cell apoptosis. By using biotin-labeled circRNA-0008717 probe to perform RNA precipitation in osteosarcoma cells, we identified miR-203 as the circ0008717-associated microRNA. Subsequently, Bmi-1 was identified as the functional target of miR-203. In addition, overexpression of circRNA-0008717 in osteosarcoma could elevate Bmi-1 expression, resulting in the promotion of osteosarcoma cell proliferation and invasion. Furthermore, the tumor promoting effect of circRNA-0008717 was abolished by miR-203 mimics or Bmi-1 silencing vector. In conclusion, circRNA-0008717 plays an oncogenic role in osteosarcoma and may serve as a promising prognostic biomarker for osteosarcoma patients. Therefore, silence of circRNA-0008717 could be a future direction to develop a novel treatment strategy.

Citing Articles

Research progress of circRNAs in bone-related diseases.

Hua X, Yu L, Zhu H, Zhu Y, Fan G, Zhou G Front Oncol. 2025; 15:1481322.

PMID: 39931083 PMC: 11807992. DOI: 10.3389/fonc.2025.1481322.


CircTIAM1 overexpression promotes the progression of papillary thyroid cancer by regulating the miR-338-3p/LASP1 axis.

Zhang Y, Liang Y, Wu Y, Song L, Zhang Z Oncol Res. 2024; 32(11):1747-1763.

PMID: 39449799 PMC: 11497179. DOI: 10.32604/or.2024.030945.


Advancements in Understanding the Role of Circular RNA in Osteosarcoma.

Wang J, Zhang Y, Li Z Mol Biotechnol. 2023; 66(9):2157-2167.

PMID: 37661210 DOI: 10.1007/s12033-023-00838-4.


Non-coding RNAs as potential biomarkers in osteosarcoma.

Fan L, Zhong Z, Lin Y, Li J Front Genet. 2022; 13:1028477.

PMID: 36338952 PMC: 9627036. DOI: 10.3389/fgene.2022.1028477.


The Emerging Roles of Circ-ABCB10 in Cancer.

Huang Z, Shan R, Wen W, Li J, Zeng X, Wan R Front Cell Dev Biol. 2022; 10:782938.

PMID: 35646916 PMC: 9136031. DOI: 10.3389/fcell.2022.782938.


References
1.
Chen L, Wang Q, Wang G, Wang H, Huang Y, Liu X . miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma. FEBS Lett. 2013; 587(9):1366-72. DOI: 10.1016/j.febslet.2013.03.007. View

2.
Holdt L, Stahringer A, Sass K, Pichler G, Kulak N, Wilfert W . Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans. Nat Commun. 2016; 7:12429. PMC: 4992165. DOI: 10.1038/ncomms12429. View

3.
Qu S, Yang X, Li X, Wang J, Gao Y, Shang R . Circular RNA: A new star of noncoding RNAs. Cancer Lett. 2015; 365(2):141-8. DOI: 10.1016/j.canlet.2015.06.003. View

4.
Zhou B, Yu J . A novel identified circular RNA, circRNA_010567, promotes myocardial fibrosis via suppressing miR-141 by targeting TGF-β1. Biochem Biophys Res Commun. 2017; 487(4):769-775. DOI: 10.1016/j.bbrc.2017.04.044. View

5.
Li P, Zhang X, Wang L, Du L, Yang Y, Li J . MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5. Carcinogenesis. 2015; 36(12):1484-93. DOI: 10.1093/carcin/bgv145. View